Propoven 2% May Join Your Sedative List Due to COVID-19
July 2020
A new double-strength propofol may hit your shelves...to help meet demand during the COVID-19 pandemic.
It’s because more patients are requiring sedation due to mechanical ventilation for COVID-19...and regular propofol and other sedatives (midazolam, etc) have been in short supply.
“Double-strength” means the product is propofol 2%, or 20 mg/mL...compared to regular propofol, which is 1%, or 10 mg/mL.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote